RecruitingNot ApplicableNCT06954337

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

1,750 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Prostate Cancer

Summary

Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial tests whether telehealth (virtual) visits are just as safe and effective as in-person visits for managing breast or prostate cancer care at Memorial Sloan Kettering Cancer Center. **You may be eligible if...** - You have breast or prostate cancer and are a patient at Memorial Sloan Kettering - You have had at least 3 prior medical oncology visits **You may NOT be eligible if...** - You are currently enrolled in a therapeutic (treatment) clinical trial - Your primary language is not supported by the hospital's system Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUsual practice pattern (UPP)

Patient follows usual practice pattern for routine care

OTHERExperimental: Enhanced Telehealth (ET)

Patient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications